Technology | March 29, 2013

EOS Imaging Receives FDA Clearance for 3-D Imaging Software

Systems features post-operative hip implant assessment

sterEOS 1.5 Orthopedic Imaging X-Ray EOS Imaging

March 29, 2013 — EOS imaging announced that its next-generation sterEOS 3-D imaging software, sterEOS 1.5, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The sterEOS 1.5 software was highlighted along with the full EOS Imaging System at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, March 19-23 in Chicago, Ill. The technology is also featured in a paper submitted for the Hip Society Awards, which was presented on Saturday, March 23.

The sterEOS software provides 3-D modeling of the spine and lower limb based on scans taken with the EOS System, and automatically calculates over 100 clinical parameters relevant to diagnosis and surgical planning. The new sterEOS 1.5 offers expanded calculation and analysis, with new capabilities to measure hip implant component position for surgery control and revision. Other key features include 3-D modelling of severe scoliosis (Cobb angle above 50°). It will be made available to existing EOS customers as a software upgrade and will be included in all new system sales.

Marie Meynadier, CEO of EOS imaging, said, “The introduction of hip arthroplasty post-operative 3-D imaging to the EOS System answers growing challenges in orthopedic surgery post-op evaluation. It also provides the first weight-bearing 3-D solution to enhance the understanding and, ultimately, treatment of total hip replacement complications such as dislocations and wear. Ongoing research supports the unique value of EOS in understanding the relation between implant position, pelvic mobility and patient function, therefore improving treatment and patient outcomes in joint arthroplasty.”

One of the first clinical applications of the new features in assessing and monitoring hip implant alignment is discussed in a paper under consideration for the Hip Society Awards, authored by Ian Clarke, Ph.D., of Loma Linda University in Loma Linda, Calif., and Jean-Yves Lazennec, M.D., of La Pitié Salpétrière Hospital in Paris, France. The study, titled “Impingement and Abrasion Risks with MOM Bearings,” reviews how metal-on-metal hip prosthesis wear is related to implant component orientation.

EOS is the first full body, low-dose 3-D imaging system, delivering a radiation dose nine times lower than that of computed radiography X-ray and 20 times lower than basic CT scans.

For more information: www.eos-imaging.com

Related Content

Nanox secures $26M supported by strategic investment from Foxconn, unveiling the Startek-inspired AI Biobed for early detection
News | X-Ray | January 16, 2020
January 16, 2020 — Nanox, an innovative medical imaging techn
Carestream’s X-ray digital tomosynthesis functionality creates three-dimensional datasets from digital radiography (DR) that can be scrolled through similar to computed tomography (CT) imaging. It received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2020. Digital tomosynthesis uses a single sweep of X-ray exposures and streamlines operator workflow by separating the process of DT exposure acquisition from image volume formation.
News | Digital Radiography (DR) | January 15, 2020
January 15, 2020 — Carestream’s X-ray digital tomosynthesis (DT) functionality, which creates three-dimensional datas
Sponsored Content | Videos | Digital Radiography (DR) | January 06, 2020
An experienced technologist and two Agfa executives talk about what distinguishes the new Agfa 100s.
Videos | Advanced Visualization | December 30, 2019
This is a hologram of a fracture from a...
 Piedmont Rockdale Hospital
News | Mobile Devices | December 19, 2019
December 19, 2019 — Piedmont Rockdale Hospital (Conyers, Ga.), a healthcare provider with a Level III Neonatal Intens
Videos | RSNA | December 18, 2019
ITN Editor Dave Fornell and ITN Consulting Editor Greg Freiherr offer a post-game report on the trends and technologi
The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fufifilm capture a parger portion of international radiology market share. Photo by Dave Fornell.

The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fujifilm capture a larger portion of international radiology market share. Photo by Dave Fornell.

Feature | Radiology Business | December 17, 2019 | Dave Fornell, Editor
December 17, 2019 — It was disclosed today that Fujifilm may buy Hitachi's diagnostic imaging business in a deal that